MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ARVN made $15,600K in revenue. -$59,200K in net income. Net profit margin of -379.49%.

Income Overview

Revenue
$15,600K
Net Income
-$59,200K
Net Profit Margin
-379.49%
EPS
-$0.9
Unit: Thousand (K) dollars
Revenue Breakdown
    • Vepdegestrant
    • Pfizer Inc.

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
15,600 9,500 41,900 22,400
Research and development
60,300 61,100 64,700 68,600
General and administrative
19,100 23,000 21,000 25,300
Total operating expenses
79,400 84,100 85,700 93,900
(loss) income from operations
-63,800 -74,600 -43,800 -71,500
Other expense, net
-100 -100 0 -300
Interest income, net
6,400 7,400 9,000 10,300
Total other income
6,300 7,300 9,000 10,000
Net loss before income taxes and loss from equity method investment
--67,300* --
Net (loss) income before income taxes
-57,500 --34,800 -61,500
Income tax expense
100 100 300 -300
Loss from equity method investment
-0* --
Net (loss) income
-57,600 -67,400 -35,100 -61,200
Unrealized (gain) loss on available-for-sale securities
-1,600 -200 400 -500
Comprehensive (loss) income
-59,200 -67,600 -34,700 -61,700
Basic EPS
-0.9 -1.042 -0.48 -0.84
Diluted EPS
-0.9 -1.045 -0.48 -0.84
Basic Average Shares
64,000,000 64,900,000 73,200,000 73,000,000
Diluted Average Shares
64,000,000 64,700,000 73,200,000 73,000,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive (loss) income-$59,200K (-170.98%↓ Y/Y)Net (loss) income-$57,600K (-169.48%↓ Y/Y)Unrealized (gain) loss onavailable-for-sale securities-$1,600K (-420.00%↓ Y/Y)Interest income, net$6,400K (-45.30%↓ Y/Y)Net (loss) incomebefore income taxes-$57,500K (-169.19%↓ Y/Y)Income tax expense$100K (-50.00%↓ Y/Y)Total other income$6,300K (-46.15%↓ Y/Y)Vepdegestrant$14,400K Pfizer Inc.$1,200K Other expense, net-$100K (loss) income fromoperations-$63,800K (-189.36%↓ Y/Y)Revenue$15,600K (-91.74%↓ Y/Y)Total operatingexpenses$79,400K (-32.37%↓ Y/Y)Research and development$60,300K (-33.59%↓ Y/Y)General andadministrative$19,100K (-28.20%↓ Y/Y)

ARVINAS, INC. (ARVN)

ARVINAS, INC. (ARVN)